Podcasts

Podcasts

Finding Genius Podcast: AI in Healthcare: Artificial Intelligence is the Way to Advance into the Next Era of Medical Technology

AI in healthcare may sound like science fiction, but thanks to Charles Fisher, Ph.D., and his company, Unlearn.ai, it is now quickly becoming a reality.
Podcasts

The Bio Report Podcast: Using AI Created Digital Twins to Accelerate Clinical Trials

Daniel Levine spoke to Charles Fisher, founder and CEO of Unlearn, about the concept of Digital Twins and the potential to accelerate clinical trials with their use.
Podcasts

Recruit Rockstars Podcast #367: How His VC-Backed Team Made Drug Development Faster

Unlearn helps biopharma companies develop drugs more efficiently by leveraging AI to reduce the number of patients required for placebo controls in clinical trials.
Podcasts

Moneyball Medicine Podcast #49: Charles Fisher on Using Digital Twins to Speed Clinical Trials

By comparing a patient’s actual record to their Digital Twin, Unlearn can estimate the treatment effect at the patient level and conduct trials with fewer patients.
Podcasts

UCSF Rosenman Institute - The Health Technology Podcast #59: Digital Twins for Clinical Trials

Charles Fisher: Digital Twins for Clinical Trials
Podcasts

Saving Minds Podcast #27: Using Artificial Intelligence to speed Alzheimer’s studie‪s‬

This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
Podcasts

The Health-Tech Podcast #111: The Story of Unlearn.ai with Charles Fisher

The Health-Tech Podcast covers the latest in health and technology through interviews with disruptive health-tech startups and leaders.
Podcasts

TomorrowScale Podcast: Your Digital Twin - Unlearn.AI

A fascinating approach to the problem of how to make clinical trials more efficient, and understand more about what may be possible with more and better patient data.
Podcasts

Bloomberg Businessweek Podcast: Using AI Digital Twins for Drug Testing

Dr. Charles Fisher, CEO of Unlearn AI, discusses creating digital clones by using artificial intelligence for use in clinical drug trials.